MONICA BAENA: Open Payments
NPI 1043882111 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,329 in 63 payments from 19 companies in 2025. Trend: 2023 $4,639 · 2024 $2,585 · 2025 $2,329
Food & beverage: $2,229Education: $100
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 10 | $393 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $357 |
| AstraZeneca Pharmaceuticals LP | 14 | $346 |
| Axsome Therapeutics, Inc. | 4 | $215 |
| HARMONY BIOSCIENCES LLC | 3 | $193 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $181 |
| Alexion Pharmaceuticals, Inc. | 1 | $126 |
| Novo Nordisk Inc | 1 | $122 |
| GENZYME CORPORATION | 1 | $80 |
| Lilly USA, LLC | 2 | $54 |
Products named: XYWAV, GLASSIA, FASENRA, Sunosi, WAKIX, LUMRYZ, STRENSIQ, TEZSPIRE.
Industry payments across DC — which companies pay providers there.
